P2-16 A SYSTEMATIC REVIEW OF PHYSICIANS' STATED ATTITUDES TOWARD SHARED DECISION-MAKING,
P2-18 SHOULD VALUE CLARIFICATION EXERCISES IN DECISION AIDS ENCOURAGE COMPENSATORY STRATEGIES?,
P2-19 ENHANCING DECISION AIDS: DEVELOPMENT AND USER-TESTING OF A DYNAMIC COMPUTER-INTERACTIVE DECISION APPLICATION (DCIDA),
P2-26 DEVELOPMENT AND USABILITY TESTING OF ANSWER: A WEB-BASED METHOTREXATE DECISION AID FOR PATIENTS WITH RHEUMATOID ARTHRITIS
P2-18 SHOULD VALUE CLARIFICATION EXERCISES IN DECISION AIDS ENCOURAGE COMPENSATORY STRATEGIES?,
P2-19 ENHANCING DECISION AIDS: DEVELOPMENT AND USER-TESTING OF A DYNAMIC COMPUTER-INTERACTIVE DECISION APPLICATION (DCIDA),
P2-26 DEVELOPMENT AND USABILITY TESTING OF ANSWER: A WEB-BASED METHOTREXATE DECISION AID FOR PATIENTS WITH RHEUMATOID ARTHRITIS
P2-22 A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5 REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
P3-5 REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION
P1-55 TOO MUCH OF A GOOD THING? WHEN TO STOP CATCH-UP VACCINATION,
P2-50 HIV TREATMENT AND PREVENTION: A SIMPLE MODEL TO DETERMINE OPTIMAL INVESTMENT,
P4-42 ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW,
TRA2-5 CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYING, MODIFIABLE RISK FACTORS: THE EXAMPLE OF SMOKING INITIATION AND QUITTING IN INDIA
P2-50 HIV TREATMENT AND PREVENTION: A SIMPLE MODEL TO DETERMINE OPTIMAL INVESTMENT,
P4-42 ARE ORGANIC FOODS SAFER OR HEALTHIER THAN CONVENTIONAL ALTERNATIVES? A SYSTEMATIC REVIEW,
TRA2-5 CALIBRATION METHODS FOR EXPOSURE TO TIME-VARYING, MODIFIABLE RISK FACTORS: THE EXAMPLE OF SMOKING INITIATION AND QUITTING IN INDIA
H-1 INFORMING CONSUMERS CHOICE OF HIGH QUALITY FACILITIES FOR ELECTIVE SURGERY: COMPARING HEALTH PLAN CENTERS-OF-EXCELLENCE DESIGNATIONS WITH PUBLICLY REPORTED QUALITY METRICS,
P2-33 PRE-AUTHORIZATION: AN EFFECTIVE MEANS OF REDUCING OVERUTILIZATION?,
P3-19 AN ONLINE TRANSPARENCY PLATFORM ENABLES PREFERENCE-APPROPRIATE BEHAVIOR CHANGE FOR CONSUMERS ON A REFERENCE-BASED PRICING BENEFIT PLAN,
P4-21 NEGOTIATED RATES FOR OUTPATIENT SERVICES: FINDING CONSIDERABLE VARIANCE EVEN WITHIN A SINGLE COMMERCIAL CARRIER'S NETWORK
P2-33 PRE-AUTHORIZATION: AN EFFECTIVE MEANS OF REDUCING OVERUTILIZATION?,
P3-19 AN ONLINE TRANSPARENCY PLATFORM ENABLES PREFERENCE-APPROPRIATE BEHAVIOR CHANGE FOR CONSUMERS ON A REFERENCE-BASED PRICING BENEFIT PLAN,
P4-21 NEGOTIATED RATES FOR OUTPATIENT SERVICES: FINDING CONSIDERABLE VARIANCE EVEN WITHIN A SINGLE COMMERCIAL CARRIER'S NETWORK
D-2 AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK,
P1-48 MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER,
P3-36 GIST (NOT VERBATIM) NUMERACY PREDICTS DIABETES MEDICATION ADHERENCE: A FUZZY-TRACE THEORY APPROACH
P1-48 MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER,
P3-36 GIST (NOT VERBATIM) NUMERACY PREDICTS DIABETES MEDICATION ADHERENCE: A FUZZY-TRACE THEORY APPROACH
P2-16 A SYSTEMATIC REVIEW OF PHYSICIANS' STATED ATTITUDES TOWARD SHARED DECISION-MAKING,
P2-18 SHOULD VALUE CLARIFICATION EXERCISES IN DECISION AIDS ENCOURAGE COMPENSATORY STRATEGIES?,
P2-19 ENHANCING DECISION AIDS: DEVELOPMENT AND USER-TESTING OF A DYNAMIC COMPUTER-INTERACTIVE DECISION APPLICATION (DCIDA)
P2-18 SHOULD VALUE CLARIFICATION EXERCISES IN DECISION AIDS ENCOURAGE COMPENSATORY STRATEGIES?,
P2-19 ENHANCING DECISION AIDS: DEVELOPMENT AND USER-TESTING OF A DYNAMIC COMPUTER-INTERACTIVE DECISION APPLICATION (DCIDA)
P1-45 USING THE NET MONETARY BENEFIT FRAMEWORK FOR THE OPTIMAL DICHOTOMIZATION OF DIAGNOSTIC TESTS: A CASE STUDY OF A DYSGLYCEMIA SCREENING PROGRAM,
P1-46 USING PROBABILITY ELICITATION TO PERFORM EARLY HEALTH ECONOMIC EVALUATIONS OF NEW MEDICAL PRODUCTS,
P2-57 USING STOCHASTIC MULTI-CRITERIA ACCEPTABILITY ANALYSIS TO SUPPORT DECISION MAKING ON THE REIMBURSEMENT OF MEDICAL INTERVENTIONS
P1-46 USING PROBABILITY ELICITATION TO PERFORM EARLY HEALTH ECONOMIC EVALUATIONS OF NEW MEDICAL PRODUCTS,
P2-57 USING STOCHASTIC MULTI-CRITERIA ACCEPTABILITY ANALYSIS TO SUPPORT DECISION MAKING ON THE REIMBURSEMENT OF MEDICAL INTERVENTIONS
J-1 BRIEF EDUCATION AND COMPLETING A CONJOINT VALUATION SURVEY REDUCE DECISIONAL CONFLICT REGARDING LUNG CANCER SCREENING AMONG INDIVIDUALS AT-RISK FOR LUNG CANCER,
P1-20 WHAT ATTRIBUTES OF A LUNG CANCER SCREENING TEST AFFECT INTEREST IN BEING SCREENED?,
P2-22 A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5 REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION,
P4-5 INDIVIDUAL CHARACTERISTICS ASSOCIATED WITH DIFFERENCES IN DESIRE FOR LUNG CANCER SCREENING
P1-20 WHAT ATTRIBUTES OF A LUNG CANCER SCREENING TEST AFFECT INTEREST IN BEING SCREENED?,
P2-22 A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5 REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION,
P4-5 INDIVIDUAL CHARACTERISTICS ASSOCIATED WITH DIFFERENCES IN DESIRE FOR LUNG CANCER SCREENING